Qi, Hai http://orcid.org/0000-0001-5475-3989
Liu, Bo
Wang, Xinquan
Zhang, Linqi http://orcid.org/0000-0003-4931-509X
Funding for this research was provided by:
National Natural Science Foundation of China (31830023, 81621002, 9216920007)
Bill and Melinda Gates Foundation (OPP1175849)
Ministry of Science and Technology of the People’s Republic of China (2020YFC0848800, 2020YFC08499, 2020YFC0861200, 2021YFC0864500)
Beijing Municipal Science and Technology Commission (Z201100005420019)
Article History
Received: 25 February 2022
Accepted: 22 April 2022
First Online: 27 June 2022
Competing interests
: L.Z. has filed patent applications for BRII-196 and BRII-198 antibodies against SARS-CoV-2 and is a share holder of Tsb Therapeutics.
Free to read: This content has been made available to all.